logo-loader
viewVersarien PLC

Versarien says graphene interest soaring after NGI collaboration

Neill Ricketts, Versarien’s chief executive, said it was seeing real demand from commercial customers.

picture of graphene-enhanced material
Interest in graphene is soaring

Versarien PLC (LON:VRS) said commercial interest in graphene has soared following a successful trial with Manchester University’s National Graphene Institute (NGI).

The company’s 2D-Tech subsidiary has worked with the NGI since 2014 on ways to strengthen carbon fibre composites using graphene

The grant-funded project has ended but the NGI has indicated it wants to buy a significant quantity of graphene from Versarien for a specific project with a major company.

Numerous other companies are now also interested.

Professor Robert Young, Professor of Polymer Science and Technology at the university, said the [unnamed]  major UK company is evaluating graphene for use in a number of different structural components with production possible within six months.

Neill Ricketts, Versarien’s chief executive, added it was seeing real demand from commercial customers. 

“We intend to significantly scale up our capacity to produce graphene to meet the demand we are seeing, which is only expected to increase."

 

Quick facts: Versarien PLC

Price: 79.5 GBX

AIM:VRS
Market: AIM
Market Cap: £122.38 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

13 hours, 50 minutes ago

2 min read